--- title: Does weight-loss surgery cure diabetes? publication: Medical Insights Korea section: faq category: Obesity canonical_url: https://medicalinsightskorea.com/faq/does-weight-loss-surgery-cure-diabetes author: David Seo published: 2026-10-27T11:00:00+09:00 modified: 2026-10-27T11:00:00+09:00 content_type: reference license: Quotation permitted with attribution to Medical Insights Korea and a link to the canonical URL. --- # Does weight-loss surgery cure diabetes? In Korean national data, 71 percent of the diabetes present before surgery was gone two years later. Whether that is a cure depends on what you mean, and the honest answer is that two years is not long. ## Answer Bariatric surgery puts most diabetes into remission rather than curing it: in a Korean national cohort of 856 people who had bariatric surgery in 2019 and 2020, the number meeting the study definition of diabetes fell by 71 percent (from 345 to 100) two years after surgery and hypertension by 52 percent, alongside a mean weight loss of 22.1 kg — while in a separate prospective Korean cohort of 116 patients, diabetes remission was 80.7 percent at one year and 85.7 percent at two, rising even as weight partly returned. ## Key takeaways - In a Korean national cohort of 856 bariatric surgery patients, those meeting the study definition of diabetes fell from 345 to 100 — a 71 percent reduction — two years after surgery. - Those meeting the definition of hypertension fell from 513 to 246, a 52 percent reduction, and fatty liver disease improved in 70 percent of cases. - Mean body weight fell by 22.1 kg, body mass index by 7.9 kg/m² and waist circumference by 17.4 cm. - 56.3 percent of patients achieved total weight loss of 20 percent or more. - In a separate prospective cohort of 116 Korean patients, diabetes remission was 80.7 percent at one year and 85.7 percent at two years. - In that cohort total weight loss peaked at 27.5 percent at eighteen months and settled at 24.7 percent at two years. - The type of operation — gastric bypass, sleeve gastrectomy or biliopancreatic diversion — was not associated with the weight outcome in either cohort. ## Full article Remission and cure are different claims, and the difference matters here. What the Korean data shows is that most patients stop meeting the criteria for diabetes. What it cannot show, at two years, is whether that lasts. **345 → 100** — patients meeting the study definition of diabetes before and two years after bariatric surgery, in a Korean national cohort of 856 _Source: Kim J et al., Journal of Obesity & Metabolic Syndrome, 2026_ ### The metabolic effect outpaces the weight In the prospective cohort of 116 patients, diabetes remission rose from 80.7 percent at one year to 85.7 percent at two — while total weight loss was falling back from 27.5 percent at eighteen months to 24.7 percent at two years. Hyperlipidaemia remission also rose, from 49.0 to 71.4 percent. Those curves moving in opposite directions is the most interesting thing in the data. If metabolic improvement were purely a function of weight, they would track each other. This is consistent with the long-standing observation that this surgery acts on glucose handling through mechanisms beyond mass alone — though a 116-patient cohort cannot establish that, and it is only the direction the numbers point. > **The number to hold alongside the 71 percent** > 56.3 percent of patients in the national cohort reached total weight loss of 20 percent or more, the threshold the study set for a sufficient result. Close to half did not. Blood pressure was also the comorbidity that moved least — hypertension remission sat at 50.0 percent at one year and was still 50.0 percent at two. Diabetes responds best; not everything does. ### Which operation Both Korean cohorts found no significant difference between procedures — gastric bypass, sleeve gastrectomy and biliopancreatic diversion with duodenal switch — in whether sufficient weight loss was achieved. What predicted it instead was younger age, female sex, a higher starting body mass index and a higher systolic blood pressure. That does not make the operations interchangeable for you personally: reflux, diabetes severity, anatomy and revision risk all still bear on the choice. It does mean expected weight loss is not the thing that separates them, so being steered towards one on those grounds is being given a reason the Korean data does not support. ### Why two years is the real limitation Diabetes is managed across decades and neither cohort has followed anyone that long. The national cohort also has no comparison group — no matched people with similar obesity who did not have surgery — so the improvement cannot be fully separated from two years of clinical attention. And meeting or not meeting a study definition based on checkup measurements is not the same as being off medication. ## Sources - Kim J, Choi HS, Kim M, Kim H, Kim KA, Lee SE. Clinical Outcomes of Contemporary Bariatric Surgical Procedures: A Nationwide Cohort Study. Journal of Obesity & Metabolic Syndrome 2026. doi:10.7570/jomes25096. PMID:42289997. https://doi.org/10.7570/jomes25096 - Choi SI, Heo Y, Ryu SW, Park S, Kwon Y, Ha TK, Lee YJ, Lee S, Seo KW, Kim SH, Park JY, Kim JH. Safety, Efficacy, and Quality of Life Outcomes of Bariatric and Metabolic Surgery in Korea: A Prospective Multicenter Cohort Study. Obesity Surgery 2026;36(6):2995-3007. doi:10.1007/s11695-026-08697-z. PMID:42098468. https://doi.org/10.1007/s11695-026-08697-z ## Citation David Seo (2026). "Does weight-loss surgery cure diabetes?". Medical Insights Korea. https://medicalinsightskorea.com/faq/does-weight-loss-surgery-cure-diabetes Retrieved from https://medicalinsightskorea.com/faq/does-weight-loss-surgery-cure-diabetes